Connect with us

Cannabis

Maker of MDMA-assisted PTSD treatment to seek US regulatory nod

[ad_1]

The back story, as a number of people have hinted to us, is that MAPS backers want a return on investment so it is time to turn the MAPS brand from education and altruism to a market driven force.

As i’ve said to a number of people. We all need to re-read our Huxley.

The path that he envisaged is on the way and quite frankly it is more than a little bit scary.

The thin end of the wedge starts here https://maps.org/mdma/

Don’t get me wrong MDMA is a wonderful thing but ………..

Reuters

Sept 15 (Reuters) – The Multidisciplinary Association for Psychedelic Studies (MAPS) plans to file for regulatory approval for the party drug MDMA as a treatment for post-traumatic stress disorder in the United States later this year, in a potential boost to the nascent psychedelic therapeutics industry.

PTSD is a disorder caused by very stressful events and can significantly disrupt patients’ lives. MDMA, used in the drug Ecstasy, is currently illegal in the U.S.

https://www.reuters.com/business/healthcare-pharmaceuticals/maker-mdma-assisted-ptsd-treatment-seek-us-regulatory-nod-2023-09-15/

[ad_2]

Sean Hocking

Source link